S Korean biopharma company Green Cross to build Cell Therapy manufacturing facility in China

Specifications:

Name:

S Korean biopharma company Green Cross to build Cell Therapy manufacturing facility in China

Location:

China

Company:

Green Cross

Estimated Cost:

-

Source:

greencross.com 

Introduction:

Green Cross, a South Korean biopharmaceutical company, today announced plans to build a new cell therapy manufacturing facility at the Guian New Area in the Guizhou province of China.

Features:

The new manufacturing site sets to address the cellular therapeutic industry’s demand for clinical studies and commercial supply. Green Cross has a robust and growing portfolio of approved and clinical stage cell therapy projects including T cell, NK cell, dendritic cell and stem cells. Cell therapy products are an increasingly significant tool in the treatment of serious diseases.

“Our investment reflects the strength of our business and the increasingly important role that cell therapy will play in Green Cross future,” said Dr. BG Rhee, President of Green Cross Holdings.